Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Female × exemestane × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 171 Neoplasm Metastasis 16 Neoplasms 6 Breast Neoplasms, Male 6 Ovarian Neoplasms 4 Breast Diseases 4 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Prostatic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bulbo-Spinal Atrophy, X-Linked 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexuality 1 Recurrence 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Pancreatic Neoplasms 1 Obesity 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1

Interventions

Tamoxifen 3 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡